SenesTech (NASDAQ:SNES) Coverage Initiated by Analysts at StockNews.com

Research analysts at StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNESGet Free Report) in a report issued on Monday. The brokerage set a “sell” rating on the stock.

SenesTech Price Performance

Shares of SenesTech stock opened at $2.37 on Monday. The business’s fifty day simple moving average is $3.51 and its 200 day simple moving average is $5.67. The company has a current ratio of 4.68, a quick ratio of 3.49 and a debt-to-equity ratio of 0.05. SenesTech has a 12 month low of $1.90 and a 12 month high of $55.26.

SenesTech (NASDAQ:SNESGet Free Report) last released its earnings results on Thursday, August 8th. The company reported ($3.08) EPS for the quarter, topping analysts’ consensus estimates of ($3.20) by $0.12. The company had revenue of $0.46 million for the quarter, compared to analysts’ expectations of $0.49 million. SenesTech had a negative return on equity of 168.64% and a negative net margin of 464.09%. During the same period in the previous year, the business posted ($84.03) EPS. Research analysts expect that SenesTech will post -11 earnings per share for the current fiscal year.

SenesTech Company Profile

(Get Free Report)

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

Featured Articles

Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.